Recent Finacing
Recent Raise
Enobia Pharma develops ENB-0040, a recombinant enzyme replacement therapy for hypophosphatasia, conducting Phase IIb pediatric clinical trials using commercially manufactured drug supply from its Montreal base.
Focus Areas
Total Raised
Funding round